These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8755 related articles for article (PubMed ID: 21846298)
1. Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-β gene therapy and cisplatin in a mouse melanoma model. Seo KW; Lee HW; Oh YI; Ahn JO; Koh YR; Oh SH; Kang SK; Youn HY Cytotherapy; 2011 Sep; 13(8):944-55. PubMed ID: 21846298 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-β and treatment with cisplatin in a xenograft mouse model for canine melanoma. Ahn Jo; Lee Hw; Seo Kw; Kang Sk; Ra Jc; Youn Hy PLoS One; 2013; 8(9):e74897. PubMed ID: 24040358 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088 [TBL] [Abstract][Full Text] [Related]
4. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft. Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis. Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Kidd S; Caldwell L; Dietrich M; Samudio I; Spaeth EL; Watson K; Shi Y; Abbruzzese J; Konopleva M; Andreeff M; Marini FC Cytotherapy; 2010 Sep; 12(5):615-25. PubMed ID: 20230221 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model. Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Ren C; Kumar S; Chanda D; Chen J; Mountz JD; Ponnazhagan S Stem Cells; 2008 Sep; 26(9):2332-8. PubMed ID: 18617688 [TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models. Park GT; Kim SU; Choi KC Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205 [TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and Growth-inhibitory Effect of IFN-β-Overexpressing Canine Adipose Tissue-derived Mesenchymal Stem Cells Against Melanoma Cells. Han SM; Park CW; Ahn JO; Park SC; Jung WS; Seo KW; Ra JC; Kang SK; Lee HW; Youn HY Anticancer Res; 2015 Sep; 35(9):4749-56. PubMed ID: 26254365 [TBL] [Abstract][Full Text] [Related]
11. The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model. Du L; Liang Q; Ge S; Yang C; Yang P Stem Cell Res Ther; 2019 Jul; 10(1):224. PubMed ID: 31358054 [TBL] [Abstract][Full Text] [Related]
13. TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice. Song WJ; Li Q; Ryu MO; Ahn JO; Bhang DH; Jung YC; Youn HY Stem Cell Res Ther; 2018 Apr; 9(1):91. PubMed ID: 29625582 [TBL] [Abstract][Full Text] [Related]
14. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β. Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807 [TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Mirzaei H; Salehi H; Oskuee RK; Mohammadpour A; Mirzaei HR; Sharifi MR; Salarinia R; Darani HY; Mokhtari M; Masoudifar A; Sahebkar A; Salehi R; Jaafari MR Cancer Lett; 2018 Apr; 419():30-39. PubMed ID: 29331419 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells modified to express interferon-β inhibit the growth of prostate cancer in a mouse model. Wang GX; Zhan YA; Hu HL; Wang Y; Fu B J Int Med Res; 2012; 40(1):317-27. PubMed ID: 22429371 [TBL] [Abstract][Full Text] [Related]
17. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases. Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597 [TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth in vitro and in vivo. Ahn JO; Coh YR; Lee HW; Shin IS; Kang SK; Youn HY Anticancer Res; 2015 Jan; 35(1):159-68. PubMed ID: 25550547 [TBL] [Abstract][Full Text] [Related]
19. Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma. Choi SA; Yun JW; Joo KM; Lee JY; Kwak PA; Lee YE; You JR; Kwon E; Kim WH; Wang KC; Phi JH; Kang BC; Kim SK Stem Cells Dev; 2016 Jun; 25(12):897-908. PubMed ID: 27151205 [TBL] [Abstract][Full Text] [Related]
20. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Ren C; Kumar S; Chanda D; Kallman L; Chen J; Mountz JD; Ponnazhagan S Gene Ther; 2008 Nov; 15(21):1446-53. PubMed ID: 18596829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]